Abstract -Important features of DNA structure and the reactions of platinum complexes with solvent and media components are reviewed. Within the context of this background information are presented details of the binding of the anticancer drugs cis-[Pt(NH3)2C12} (cis-DDP), [Pt(en)C12], and [Pt(NH3)2(CBDCA)] (carboplatin), as well as the chemotherapeutically inactive isomer trans-DDP, to DNA. After hydrolysis of the chloride ligands fromcis-DDP, the {Pt(NH3)2}2+ moiety primarily forms a crosslink between adjacent guanosine nucleosides on the same strand of the DNA double helix. The resulting adduct has been structurally characterized on single-stranded DNA in the solid state by X-ray diffraction and on single-stranded and duplex DNA in solution by NMR spectroscopy. Platinum binds to the N7 atoms of the guanine rings, unstacks the bases, and switches the sugar pucker of the 5'-nucleotide from C2'-endo to C3'-endo. Molecular mechanics calculations of both single-and double-stranded DNA-platinum adducts have been carried out to model additional features of the structures. An intrastrand crosslink also forms between adjacent adenosine and guanosine nucleosides in DNA treated with cis-DDP. Studies with nonoclonal antibodies demonstrate that cis-[Pt(NH3)2{d(pGpG)}] and cis-[Pt(NH3)2{d(pApG)}] adducts on duplex DNA are structural analogs of one another, and that carboplatin forms the same adducts as cis-DDP. The regioselectivity of cis-DDP and [Pt(en)C12] binding to DNA is controlled by local sequences in which the principal d(pGpG) targets are embedded. This selectivity can be modified by addition of external intercalators, such as ethidium bromide, during the platination reaction. Similar behavior occurs for AO-Pt, a novel molecule in which dichloroethylenediamineplatinum(II) is linked by a hexamethylene chain to acridine orange. The preferred binding sites of trans-DDP on single-stranded DNA have also been mapped. This isomer forms intrastrand crosslinks between two guanosines, or an adenosine and guanosine, having one or more intervening nucleotides. Structural studies by NNR spectroscopy have been carried out on trans-{Pt(NH3)2} adducts of d(GpTpG) (N7-G(1),N7-G(3)), d(GpCpG) (N7-G(1),N7-(G(3)), and [d(ApGpGpCpCpT)}2 (N7-A(1),N7-G(3)). Antinucleoside antibodies show clearly that trans-DDP adducts are more disruptive of the DNA double helix than those formed by cis-DDP since the intervening nucleotides in the former cannot form Watson-Crick base pairs with their complements on the unplatinated strand. A strategy for investigating the cytotoxicity, mutagenicity, and repair of intra-and interstrand crosslinks formed by cis-DDP, trans-DDP, and their analogs is presented. Specifically, construction of M13 DNA containing the cis-[Pt(NH3)2{d(pGpG)}] adduct built into a unique, programmable site in the genome is described. Chemical and biological studies of such substrates should enable unambiguous information to be obtained about the viability and lethality of individual Pt-DNA adducts in vivo and, ultimately, lead to the design of better heavy metal anticancer drugs.
INTRODUCTION Brief clinical history
The discovery of anticancer activity in mice of cis-diamminedichloroplatinum(II), cis-DDP or cisplatin, and the finding that the isomer trans-DDP is inactive were reported in the late 196Os.1 Following extensive clinical trials, cisplatin was approved by the U. S. Food and Drug Administration in 1979. It has subsequently become a leading selling anticancer drug, being most effective against testicular, ovarian, and head and neck tumors.2 Although other cis-[Pt(NR3)2X2] complexes, such as [Pt(en)C12], exhibit anticancer activity, only one, cis-[Pt(NH3)2(CBDCA)}, where CBDCA = cyclobutane-1,1-dicarboxylate, or carboplatin, has been released in the United Kingdom for the treatment of tumors, owing to its less toxic side effects compared to cisplatin. 3 The failure of patients to respond to cisplatin chemotherapy is often accompanied by resistance to the drug. Understanding the biochemical mechanisms by which cis-DDP is toxic to tumor cells at doses that normal cells can withstand, by which trans-DDP is rendered ineffective at doses where cis-DDP is active, and by which cells become resistant to cis-DDP are objectives that have attracted a wide range of scientists, from inorganic chemists to cell biologists, to join forces to work in this area. DNA as the target Evidence pointing to DNA replication as the major function impaired by cis-DDP in the tumor cell, responsible for its cytotoxicity and anticancer activity, has been summarized elsewhere. 5 The ability of cis-DDP adducts on DNA to stop the processive action of DNA polymerase translates into inhibition of cell division and, hence, antitumor activity.
HN
Recent studies of the inhibition of replication of viral DNA in simian virus 40 (SV40) ininfected African green monkey kidney (CV-1) cells illustrate the dramatic difference in the effects of cis-versus trans-DDP in the cell culture medium. 6 As shown in Fig. 1 , 10 M cis-DDP inhibits SV4O DNA replication to 75% of control (no Pt present), a concentration at which trans-DDP is ineffective. At higher concentrations, however, the trans isomer also inhibits DNA synthesis in this system. The inhibition of SV4O DNA replication is a function of the amount of platinum bound per nucleotide for both isomers.6
Once it was generally accepted that DNA is a principal target for cis-DDP in cells, responsible for its cytotoxicity, attention turned to identifying the major binding modes of platinum to this biopolymer (Fig. 2) . DNA interstrand crosslinking7 and protein-DNA crosslinks8 were readily identified, owing to the relative ease of detecting reactions that covalently link macromolecules under denaturing conditions. Although suggested early,9 characterization of DNA intrastrand crosslinks was more difficult.102 Platinum induced intrastrand crosslinking occurs most frequently in the reactions of cis-DDP with DNA, and consequently serves as a focus for much of the following discussion. Scope of this article
The present article summarizes important structural details of the adducts of cisplatin with DNA. Much progress has been made since a review of this topic only two years ago. 13 Moreover, in this time period, attention has also turned to understanding DNA reaction products of trans-DDP. For, even though the trans isomer is inactive, knowledge of its DNA binding modes is important as a means of calibrating the biological consequences of cis-DDP-DNA adducts. These new findings are also discussed here. DNA is possibly the most complex multidentate ligand studied by coordination chemists. The ability to make progress in unravelling the regio-and stereochemistry and -specificity of its platinum binding properties was greatly facilitated by joint efforts of scientists applying newly emerging methodologies from the diverse disciplines of molecular biology, cell biology, immunology and bioinorganic chemistry. This article tries to capture the spirit of such a collaborative enterprise. 
DNA polymorphism
The three-dimensional structure of duplex DNA is sensitive to local sequence. The classical form of DNA is the B structure, with well-defined major and minor grooves, C2'-endo deoxyribose sugar puckers, and parallel stacked base pairs running perpendicular to the helix axis.15 A, C, D, and left-handed Z forms of DNA also exist, however (Fig. 4) 
CI,NH Cl Hydrolysis and media reactions
The aqueous solution chemistry of platinum(II) complexes has been reviewed previously.21 Eq. (1) illustrates the stepwise hydrolysis reactions of both cis-and trans-DDP to form aqua species that can deprotonate at physiological pH. Although chloride ion is a better trans
labilizing ligand than ammonia, it is also a better leaving group. 22 The first product formed is therefore [Pt(NH3)2Cl(0H2)}+, rather than [Pt(NH3)Cl2(0H2)}. The compounds cis-and trans-DDP hydrolyze according to eq. (1) with retention of stereochemistry. Subsequent reactions with DNA also occur with retention of stereochemistry.
The presence of chloride ion in plasma and cells modulates the reactivity of cis-and trans-DDP in vivo, according to eq. (1). It is generally accepted that the drug, typically administered as an intravenous injection, is activated upon crossing cellular membranes. During this process, the chloride ion concentration drops from 0.1 M to 3 mM, producing greater quantities of the kinetically more reactive aquated complexes according to eq. (1).23 It is these hydrolyzed forms that react with DNA.
Platinum complexes also bind other components in media commonly used in cell culture experiments, with trans-DDP being more reactive, and hence more rapidly inactivated, than cis-DDP. In carrying out comparative studies with cis-DDP and trans-DDP, it is advisable, for example, to keep fetal calf serum concentrations below 5% and to avoid normal mouse serum.2'+ Platinum complexes also react with glutathione, metallothionein, and amino acids.25'26 Although millimolar concentrations of glutathione (GSH) are present in cells, depletion of GSH levels has little effect on the cytotoxicity of cis-DDP, [Pt(en)Cl2}, or carboplatin, although it does potentiate the toxicity of trans-DDP. Intravenous infusion of diethyldithiocarbonate28 or thiosulfate29 reduces nephrotoxicity when administered in conjunction with cisplatin chemotherapy.
These various anecdotal cases illustrate the effects of sulfur donor ligands on the molecular biology of platinum complexes, as expected from hard-soft acid-base principles of coordination chemistry. This potential reactivity must be kept in mind when designing and interpreting mechanism of action studies of platinum anticancer drugs.
Owing to its excellent solvation properties, dimethyl sulf oxide (Me2SO) is commonly used to dissolve compounds in biological studies. Many of the earliest experiments with cisplatin employed Me2SO as solvent,7 a practice which unfortunately has persisted.30'31 Kinetic studies reveal that Me2SO substitutes for a single chloride ligand according to eq. (2) for both (2) cis-and trans-DDP, a reaction that can be followed by 195Pt NMR spectroscopy (Fig. 5) 
ADDUCTS FORMED WHEN cis-DDP AND RELATED MOLECULES BIND TO DNA Enzymatic and chromatographic mapping of adducts
When cis-DDP binds to DNA, it promotes superhelical unwinding and shortens the double helix. The shortening but not the unwinding can be eliminated if the intercalator ethidium bromide is present during platination.35 Subsequent removal of ethidium by dialysis restores the DNA shortening effect. These results suggested two modes of cis-DDP binding to DNA. One mode results in short-range intrastrand crosslinks and superhelical unwinding. The second, ethidium bromide dependent, binding mode involves long-range crosslinks that are slower to form.
Enzymatic mapping studies of DNA platinated by cis-DDP'02 ,36 or [Pt(en)Cl2137 revealed a strong preference for binding to sequences containing two or more adjacent guanosine nucleosides. The quantitization of these and other, less common, adducts was achieved by first degrading DNA platinated in vitro38° or in vivo with a combination of nucleases and then separating and identifying the resultant fragments by chromatography and, for the in vivo study, immunochemical techniques. These studies revealed that intrastrand d(GpG) crosslinks account for 65% of the adducts formed in vitro and 35% of those formed in vivo. In addition, the in vitro results revealed that 25% of the platinum forms d(ApG) intrastrand crosslinks, with long-range intrastrand and interstrand G-G crosslinks and monofunctional binding accounting for the remaining 10% of bound platinum. In vivo, the interstrand and DNA-protein crosslinks each amounted to less than 0.2% of the adducts found at bound drug When the intercalator ethidium bromide (EthBr) was present during platination, however, these became preferred sequences for drug binding. The most common such sequences contained the d(pCpGpG) trinucleotide, and it was postulated that this sequence might perturb local DNA structure such as to render inaccessible guanosine N7 atoms, the preferred binding sites for platinum on DNA.37 Restoration of a more normal, B-DNA type local structure could occur upon addition of EthBr, activating the site for platinum binding.
The ability of an intercalator to restore platinum binding to such sequences will depend in part upon its mean residence time at the site. Thus, acridine orange (A0), which dissociates from its sites of intercalation on DNA more rapidly than EthBr,8 fails to activate binding sites inaccessible to cis-DDP and [Pt(en)C121 at low D/N ratios.37 On the other hand, AO-Pt, a molecule in which the acridine orange ring is tethered to ethylenediamineplatinum(II) by a -(-CH2-)-6 chain, is able to bind at these positions. This molecule effectively raises the local platinum concentration near the site of intercalation such that binding to form the d(GpG) crosslink can occur before the acridine moiety dissociates and the DNA can relax to its unmodified structure. Irradiation of AO-Pt-DNA adducts by visible light results in cleavage of the sugar-phosphate backbone of the biopolymer near the sites of platinum binding.20 Thus, molecules of this kind have the interesting potential for self-mapping the regiospecificity of their DNA binding chemistry.
STRUCTURAL STUDIES OF MAJOR cis-DIAMMINEPLATINUM-DNA ADDUCTS Dinucleotides
Proton NMR spectroscopic studies of chromatographically purified cis-diammineplatinum(II) adducts of several ribo-and deoxyribonucleotides have been carried out. Intrastrand crosslinks between two N7 guanosine or adjacent 5' adenosine and 3' guanosine nucleosides were characterized for (GpG),9'50 d(GpG),50'51 d(pGpG),50 and (ApG).52 Assignment of platinum binding sites was facilitated by the fact that coordination of the heavy metal to N7 of guanosine lowers the pKa of the Ni proton by "2 units (Fig. 6) , a phenomenon readily detected by monitoring the pH dependence of the chemical shift of the H8 proton NNR resonance. A conformational analysis51 of cis-[Pt(NH3)2{d(GpG)} ] revealed a switch in the conformation of the 5' deoxyribose ring from C2'-endo to C3'-endo upon platination and anti conformations about both glycosidic linkages (Figs. 3 and 6) . Similar results were obtained from NMR studies of cis-fPt(N113)2-(ApG)]+.52 Coupling constants, such as Hi'H2',2", and nuclear Overhauser effects for the non-exchangeable base and sugar protons facilitate these conformational assignments.
A single crystal X-ray diffraction study of cis-fPt(NH3)2{d(pGpG)}] supplied several additional important geometric details of this, the major adduct of cis-DDP with DNA. 53 As illustrated in Fig. 7 , coordination of cis-diammineplatinum(II) to two adjacent guanosine nucleosides at N7 positions closes a 17-membered ring. The backbone compression enforced by this intrastrand crosslink results in a C3'-endo sugar pucker at the 5' nucleoside. The two guanine base planes are completely destacked, forming a dihedral angle in the 76.2(5) -86.7(6)°range for the four independent molecules in the crystal lattice. Average Pt-N bond lengths of 2.00 -2.04 are in the normal range for platinum-ammine or -pyridine complexes. Hydrogen bonding occurs between the 5' terminal phosphate oxygen atom and a coordinated ammine, OP1A' • 'Nil in Fig. 7 . One interesting aspect of the structure, revealed by examining space filling computer graphics displays, is that the exocyclic 06 atoms of the guanosine rings, oriented in a headto-head fashion on the same side of the platinum coordination plane, block access by a fifth ligand. This feature might be important in designing new heavy metal anticancer drugs. (Fig. 7) •53 Numerous other NMR studies of singlestranded60'668 and duplex6971 platinated ohigonucleotides, containing from 4 to 12 nucleotides, have been reported. In general, these compounds exhibit the same geometric features found in shorter platinated ohigomers, with a C3'-endo sugar pucker on the 5'-modified guanosine. It is significant that the
, where asterisks denote the platinum binding sites, again resemble cis-[Pt-(NH3)2{d(pGpG)}1 in that N7 coordination of adjacent nucleosides occurs with simultaneous repuckering of the 5' sugar to the C3'-endo conformation. In addition, the molecules are doublestranded below 25 °C. The formation of a kink at the site of platination has been postuhated.6970 Molecular mechanics calculations support the notion that such a kinked structure might be stable,72'73 but unkinked models involving some disruption of base pairing, especially at the 5' coordinated guanosine nucleoside, are also energetically feasible.73'7 Additional NMR and other biophysical studies of double-stranded ohigonucleotides containing the cisdiammineplatinum(II) crosshink between adjacent guanosine nucleosides are required to discern the conditions under which linear and kinked duplex structures might exist. This latter study offered a nice rationale for why, in an (ApGpA) sequence in double-stranded nucleic acids, cis-diammineplatinum(II) will prefer to coordinate to N7 atoms of the ApG, rather than the GpA, site. Following its coordination to N7 of G(2), the platinum atom is 3 A from N7 of A(1) and 5 A from N7 of A(3), hence its preference for binding to the 5' nucleoside. As described above, cis-{Pt(NH3)2{d(ApG)}} adducts are relatively common for DNA platmated with cis-DDP, whereas d(GpA) intrastrand crosslinks are not.
trans-DDP BINDING TO OLIGONUCLEOTIDES AND DNA Replication mapping of binding sites Until recently, structural details of the binding of trans-DDP were unavailable, largely owing to the disinterest in studying the chemotherapeutically inactive analog. Neglect of trans-DDP-DNA binding modes is unjustified, however, for they help to rule out aspects of the molecular mechanism of the cis isomer. trans-Diamminedichloroplatinum(II) hydrolyzes more rapidly and forms both DNA-protein and DNA interstrand crosslinks somewhat more efficiently than cis- Fig. 8 . The large, 23-membered ring containing the platinum atom and part of the destacked deoxyguanosine nucleoside in Fig. 8 may be contrasted with the smaller, 17-membered, _{Pt(NH3)2}2+_containing ring in Fig. 7 . Exactly how the trans-DDP adducts distort double-stranded DNA structure is important to learn, for geometric differences between the cis-and trans-DDP crosslinks may correlate with their different biological activities. 
DNA
As with the cis isomer, binding of trans-DDP to DNA unwinds and shortens the double helix,19'3 although reports differ about their relative abilities to do so.
Both phenomena depend critically upon the ratio of bound platinum per nucleotide. Recent experiments with antibodies provide some fresh insights into DNA structural distortions induced by trans-DDP adducts. Anti-nucleoside antibodies recognize trans-DDP-modified DNA significantly better than cis-DDPmodified DNA at comparably low D/N ratios ( O.O2).6 Moreover, a monoclonal antibody has now been developed for trans-DDP-modified calf thymus DNA, and the only double-stranded, synthetic DNA polymer to which this antibody binds was shown to be trans-{Pt(NH3)2}2-platinated poly-[d(GT)}poly[d(CA)J.5 Taken together, these results are consistent with the occurrence of trans_{Pt(NH3)2}2+_induced 1,3-intrastrand crosslinks of the kind shown in Fig. 8 in duplex DNA platinated with trans-DDP, accompanied by considerable base pair disruption and helix destacking. NNR and X-ray structural investigations of double helical DNA containing trans-DDP adducts should further clarify the situation, and reveal any additional binding modes.
Monofunctional Pt-DNA adducts Although both cis-and trans-DDP form monofunctional adducts on DNA,380 ,78 ,79 where the {Pt(NH3)2}2+ unit is coordinated to only one donor atom from the polynucleotide, a recent study reveals the number and lifetime of such adducts to be much greater for platination by the trans isomer.8 This work suggests that the second link to a monofunctional trans-DDP-DNA adduct is more likely to occur to a ligand from some source other than DNA, compared with similar cis-DDP-DNA monofunctional adducts.
BIOLOGICAL CONSEQUENCES OF PLATINUM-DNA ADDUCTS
The foregoing discussion highlights differences between the most prevalent, intrastrand crosslinks formed by cis-versus trans-DDP on DNA. How might this information be used to understand the different cytotoxic effects of the two isomers? It is impossible within the scope of the present article to discuss fully all ramifications of this question, for it involves at least the relative abilities of Pt-DNA adducts to inhibit replication, be repaired, cause mutations, and possibly induce drug resistance. Moreover, while it has been possible to reach a consensus on the regioselectivity and stereospecificity of platinum-DNA adducts for both cis-and trans-DDP, such has not yet been the case for questions related to the differential inhibition of replication, mutation induction, and repair of specific adducts. Different protocols used by investigators in different laboratories contribute in part to this situation, since covalent reactions of platinum ammine chloride complexes are sensitive to incubation times and to components in media used to dissolve them and nurture cells. One attractive approach to sorting out these problems is described in the following section.
SITE-SPECIFICALLY PLATINATED DNA
The reaction of platinum complexes with DNA in vitro or in vivo leads to a variety of products in which platinum atoms are located at numerous sites in the genome. It is inherently difficult to discern, using this globally platinated DNA, the consequences of position and structure of any one adduct on DNA function. To address this problem, a new probe of the biological activity of platinum anticancer drugs has been developed in which the cis_{Pt(NH3)2}2+ fragment is located in a unique, programmable site on the genome.85 ,86 As shown in Fig. 9 , this material is prepared by ligating a chemically synthesized oligonucleotide containing the desired platinum adduct into a gapped duplex obtained by recombinant DNA techniques. The resulting site-specifically modified genome can then be used for various repair, mutagenesis, and survival studies both in vitro and, following its introduction into cells by transformation, in vivo. 
CONCLUDING REMARKS
The major DNA adducts formed between platinum anticancer drugs and their inactive analogs have been mapped and structurally characterized, combining modern DNA sequencing and synthetic technologies with structurally powerful methods of NMR spectroscopy and X-ray diffraction. This goal could not have been achieved in 1969, the year in which the anticancer activity of cis-DDP was reported, for many of the methodologies employed were simply not available at that time.
How any or all of these platinum-DNA complexes leads ultimately to cytotoxicity and anticancer activity are subjects •for future studies. Knowledge of these in vivo processes should, ultimately, lead to the more rational design of platinum and other metal based anticancer drugs.
